NDC Labeler Indoco Remedies Limited
Indoco Remedies Limited labeler's code is 14445. The labeler has 42 products that have an assigned National Drug Code.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
---|---|---|---|---|---|---|
14445-106 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-107 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-108 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-109 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-110 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-111 | Olanzapine | Olanzapine | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-129 | Lacosamide | Lacosamide | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-130 | Lacosamide | Lacosamide | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-131 | Lacosamide | Lacosamide | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-132 | Lacosamide | Lacosamide | Tablet | Oral | Human Prescription Drug | ACTIVE |
14445-149 | Apixaban | Apixaban | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
14445-150 | Apixaban | Apixaban | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
14445-156 | Febuxostat | Febuxostat | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
14445-157 | Febuxostat | Febuxostat | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
14445-400 | Brimonidine Tartrate | Brimonidine Tartrate | Solution/ Drops | Ophthalmic | Human Prescription Drug | ACTIVE |
14445-404 | Dorzolamide Hydrochloride | Dorzolamide | Solution/ Drops | Ophthalmic | Human Prescription Drug | ACTIVE |
14445-405 | Dorzolamide Hydrochloride Timolol Maletae | Ddorzolamide Hydrochloride Timolol Maleate | Solution/ Drops | Ophthalmic | Human Prescription Drug | ACTIVE |
14445-406 | Lacosamide | Lacosamide | Injection | Intravenous | Human Prescription Drug | ACTIVE |
14445-407 | Succinylcholine Chloride | Succinylcholine Chloride | Injection | Intramuscular; Intravenous | Human Prescription Drug | ACTIVE |
14445-412 | Acetylcysteine | Acetylcysteine | Injection | Intravenous | Human Prescription Drug | ACTIVE |
14445-413 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | Injection | Intravenous | Human Prescription Drug | ACTIVE |
14445-414 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | Injection | Intravenous | Human Prescription Drug | ACTIVE |
14445-001 | Allopurinol | Powder | Bulk Ingredient | UNFINISHED | ||
14445-002 | Betaxolol Hydrochloride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-003 | Brimonidine Tartrate | Powder | Bulk Ingredient | UNFINISHED | ||
14445-004 | Dicycloamine Hydrochloride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-006 | Dorzolamide Hydrochloride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-007 | Rasgiline Mesylate | Powder | Bulk Ingredient | UNFINISHED | ||
14445-008 | Bromfenac Sodium | Powder | Bulk Ingredient | UNFINISHED | ||
14445-009 | Olopatadine Hydrochloride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-010 | Brinzolamide | Powder | Bulk Ingredient | UNFINISHED | ||
14445-011 | Febuxostat | Powder | Bulk Ingredient | UNFINISHED | ||
14445-012 | Lacosamide | Powder | Bulk Ingredient | UNFINISHED | ||
14445-013 | Besifloxacin Hydrochloride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-014 | Apixaban | Powder | Bulk Ingredient | UNFINISHED | ||
14445-015 | Neostigmine Methylsulfate | Powder | Bulk Ingredient | UNFINISHED | ||
14445-016 | Alogliptin Benzoate | Powder | Bulk Ingredient | UNFINISHED | ||
14445-017 | Canagliflozin | Powder | Bulk Ingredient | UNFINISHED | ||
14445-018 | Glimepiride | Powder | Bulk Ingredient | UNFINISHED | ||
14445-019 | Aripiprazole | Powder | Bulk Ingredient | UNFINISHED | ||
14445-021 | Lacosamide | Powder, For Solution | Bulk Ingredient | UNFINISHED | ||
14445-022 | Metoprolol Succinate | Powder | Bulk Ingredient | UNFINISHED |